Amelia J. Averitt, MPH, MA
PhD Student, Perotte Lab
Columbia University Department of Biomedical Informatics
I am a health researcher with several years of academic and industry experience. My research interests include the invention and application of statistical and computational methods to answer complex health problems. In my pre-doctoral position at Columbia University, I work with Dr. Adler Perotte. Together, we develop novel probabilistic models to support causal claims generated from observational data. Prior to my doctoral candidacy, I completed a masters degree in Biostatistics and Epidemiology at Columbia University Mailman School of Public Health. Advised by Dr. Stephen Morse, I developed a technique to quantify the economic impact of emergent infectious diseases, and built a statistical model to investigate the motiviating and mitigating factors of these economic damages, using SARS as a case study.
Salvage Regimens Containing Darunavir, Etravirine, Raltegravir, or Enfuvirtide in Highly Treatment-Experienced Perinatally Infected Pregnant Women. Gail F. Shust, Jennifer Jao, Gabriela Rodriguez-Caprio, Roberto Posada, Katherine T. Chen, Amelia Averitt, and Rhoda S. Sperling. Journal of Pediatric Infectious Disease Society. Accepted Feb 21, 2013. doi:10.1093/jpids/pit019.
Economic Burden of Irritable Bowel Syndrome with Diarrhea: Retrospective Analysis of a U.S. Commercially Insured Population. Jessica L. Buono, MPH; Kush Mathur, MS; Amelia J. Averitt, MPH; and David A. Andrae, PhD. JMCP. Nov 2016.
Economic Burden of Treatment Failure Among US Commercially Insured Patients with Irritable Bowel Syndrome with Diarrhea.
Jessica L. Buono, Kush Mathur, Amelia Averitt, David A. Andrae. AMCP Nexus. Orlando, FL. 2015
Economic Burden of Irritable Bowel Syndrome With Diarrhea: Retrospective Analyses of a US Commercially Insured Population.
Jessica L. Buono, Kush Mathur, Amelia Averitt, David A. Andrae. American College of Gastroenterology. Honolulu, Hawaii. 2015
Hospital Crossover of Patients with Sickle Cell Disease in a Health Information Exchange. B. Slovis, A. Averitt, J. Shapiro, G. Kuperman, J. Glassberg, T. Lowry. ACEP. Las Vegas, NV. 2016
Standardization of FDA Adverse Event Reporting System to the OHDSI Common Data Model. Amelia J. Averitt, Adler Perotte. AMIA. Chicago, IL. 2016